Clinical Trial Update: Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating VSL#3 Original De Simone Formulation in patients with cirrhosis has completed, reporting on cognitive function, risk of falls, and qu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Cognitive Dysfunction

Drugs mentioned

• VSL#3

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Cirrhosis, Cognitive Dysfunction | Phase 4 | Status: COMPLETED